These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 19222549)

  • 1. Vitiligo and multiple sclerosis in a patient treated with interferon beta-1a: a case report.
    Kocer B; Nazliel B; Oztas M; Batur HZ
    Eur J Neurol; 2009 Apr; 16(4):e78-9. PubMed ID: 19222549
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoimmune hepatitis and interferon beta-1a for multiple sclerosis.
    Duchini A
    Am J Gastroenterol; 2002 Mar; 97(3):767-8. PubMed ID: 11922585
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic myeloid leukaemia in two multiple sclerosis patients on interferon beta-1a.
    Almeida L; Neves M; Cardoso E; Melo A
    J Clin Pharm Ther; 2009 Feb; 34(1):125-7. PubMed ID: 19125911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hepatitis secondary to interferon beta-1a in multiple sclerosis.
    Christopher V; Scolding N; Przemioslo RT
    J Neurol; 2005 Jul; 252(7):855-6. PubMed ID: 15742101
    [No Abstract]   [Full Text] [Related]  

  • 5. Recurrent nephrotic syndrome in patient with multiple sclerosis treated with interferon beta-1a.
    Tola MR; Caniatti LM; Gragnaniello D; Russo M; Stabellini N; Granieri E
    J Neurol; 2003 Jun; 250(6):768-9. PubMed ID: 12862038
    [No Abstract]   [Full Text] [Related]  

  • 6. Panniculitis and lipoatrophy after subcutaneous injection of interferon beta-1b in a patient with multiple sclerosis.
    O'Sullivan SS; Cronin EM; Sweeney BJ; Bourke JF; Fitzgibbon J
    J Neurol Neurosurg Psychiatry; 2006 Dec; 77(12):1382-3. PubMed ID: 16782776
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon-beta treatment in patients with childhood-onset multiple sclerosis.
    Mikaeloff Y; Moreau T; Debouverie M; Pelletier J; Lebrun C; Gout O; Pedespan JM; Van Hulle C; Vermersch P; Ponsot G
    J Pediatr; 2001 Sep; 139(3):443-6. PubMed ID: 11562627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic lupus erythematosus induced by interferon β1 therapy in a patient with multiple sclerosis.
    Bahri DM; Khiari H; Essouri A; Laadhar L; Zaraa I; Mrabet A; Meddeb N; Sellami S
    Fundam Clin Pharmacol; 2012 Apr; 26(2):210-1. PubMed ID: 21323997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon beta-1A: new preparation. A short-term impact on the course of multiple sclerosis.
    Prescrire Int; 1998 Oct; 7(37):142-3. PubMed ID: 10915418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local reactions after subcutaneous injections of beta-interferon.
    van Rengen A; Goossens A
    Contact Dermatitis; 1998 Oct; 39(4):209. PubMed ID: 9817241
    [No Abstract]   [Full Text] [Related]  

  • 11. Mixed panniculitis secondary to interferon beta-1a therapy in a woman with multiple sclerosis.
    Cuesta L; Moragón M; Pérez-Crespo M; Onrubia J; García M
    Actas Dermosifiliogr; 2013 Apr; 104(3):257-9. PubMed ID: 22980355
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac arrhythmia induced by interferon beta-1a.
    Kastalli S; El Aïdli S; Mourali S; Zaïem A; Daghfous R; Lakhal M
    Fundam Clin Pharmacol; 2012 Apr; 26(2):207-9. PubMed ID: 21352349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drug information.
    JAAPA; 2009 Dec; 22(12):14. PubMed ID: 24887461
    [No Abstract]   [Full Text] [Related]  

  • 14. Meningioma growth during interferon beta-1A treatment for multiple sclerosis.
    Gama HP; Rocha AJ; Silva CJ; Mendes MF; Veiga JC; Lancellotti CL; Andrade VP; Tilbery CP
    Arq Neuropsiquiatr; 2008 Jun; 66(2B):402-4. PubMed ID: 18641881
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial.
    Comi G; De Stefano N; Freedman MS; Barkhof F; Polman CH; Uitdehaag BM; Casset-Semanaz F; Hennessy B; Moraga MS; Rocak S; Stubinski B; Kappos L
    Lancet Neurol; 2012 Jan; 11(1):33-41. PubMed ID: 22146409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythema elevatum et diutinum, multiple sclerosis and interferon beta.
    Gil M; Chizzolini C; Kaya G; Hauser C
    Dermatology; 2004; 209(1):75-6. PubMed ID: 15237277
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis.
    Webster GF; Knobler RL; Lublin FD; Kramer EM; Hochman LR
    J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):365-7. PubMed ID: 8655728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon beta retinopathy in a patient with multiple sclerosis.
    Post JW; Colleaux K
    Can J Ophthalmol; 2009 Oct; 44(5):e37. PubMed ID: 19798812
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical efficacy and safety of long-term immunomodulating therapy with interferon beta].
    Demina TL; Khachanova NV; Davydovskaia MV; Popova NF; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(4):24-6. PubMed ID: 18567192
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interferon beta-1b in multiple sclerosis--news regarding open questions].
    Nervenarzt; 1997 Aug; 68(8 Suppl Interferon):1-4. PubMed ID: 9380220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.